Section 1: The GLP-1 Bowel Connection Why Bowel Changes Happen with GLP-1 Medications GLP-1 (Glucagon-Like Peptide-1) medications are popular for promoting rapid weight loss and better blood sugar control
Study supports utilizing weight history assessment for eating disorders and shows pivotal role of GLP-1 in link between weight loss and binge eating severity Study supports utilizing weight history assessment for eating disorders and shows pivotal role of GLP-1 in link between weight loss and binge eating severity A groundbreaking study from Florida State University has uncovered the biological and behavioral consequences of weight loss that underlie binge eating in women with bulimia nervosa and related syndromes

found that the gut microbial diversity and some specific gut microbiota with heritability are associated with the variants in these genes encoding ghrelin, MC4R, GLP-1, NPY, and PYY and metabolic diseases, revealing that, to some extent, the intricate links between host genetics and gut microbiota are related to appetite modulation, which expands our understanding of the functional attributes of the gut microbiome in metabolic and eating disorders as well as open new therapeutic manipulation of specific microbiota [219]
Supplied strictly for laboratory research purposes only
Researchers at UC Irvine issue a warning that GLP-1RAs may be dangerous for children Source: UC Irvine School of Medicine Irvine, CA, August 28, 2023 A team of clinicians, exercise scientists, pharmaceutical scholars, ethicists and behavioral experts at the University of California, Irvine, outlined their concerns that the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) to treat childhood obesity and type 2 diabetes may have unintended and adverse consequences for childrens health
This post is for educational purposes only